Nov
18
2016
On November 3, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for ibrutinib (Imbruvica) for first-line treatment of chronic lymphocytic leukemia (CLL).
Nov
18
2016
On November 3, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for ibrutinib (Imbruvica) for Waldenstrom's Macroglobulinemia (WM).
Oct
17
2016
On September 29, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for idelalisib (Zydelig) for follicular lymphoma.
Oct
05
2016
Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for VENCLEXTA™ (venetoclax), a promising oral therapy for the treatment of patients with chronic lym
Aug
15
2016
Lymphoma Canada is pleased to award its 2016 Research Fellowship to Dr. Anja Mottok, a pathologist and research fellow at the British Columbia Cancer Agency.
Aug
04
2016
On July 19, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for ibrutinib (Imbruvica) for Mantle Cell Lymphoma (MCL).
Jul
08
2016
If you have CLL or SLL and have been treated with venetoclax you can help by completing our survey.
May
19
2016
A new online tool that helps Canadian patients and caregivers get the information they need and help alleviate anxiety or confusion they may be feeling after a chronic lymphocytic leukemia (CLL) diagnosis.
May
19
2016
A unique app has been developed to help you: the Tired of Cancer app. The Tired of Cancer app deals with a specific problem – fatigue – that so many (former) cancer patients suffer from, often long after their treatment.
